Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Periodontal Disease in Patients Receiving Dialysis.

Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H.

Int J Mol Sci. 2019 Aug 3;20(15). pii: E3805. doi: 10.3390/ijms20153805. Review.

2.

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.

Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H.

Int J Mol Sci. 2019 Jul 11;20(14). pii: E3413. doi: 10.3390/ijms20143413. Review.

3.

Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis.

Kitamura M, Tateishi Y, Sato S, Kitamura S, Ota Y, Muta K, Yamashita H, Uramatsu T, Obata Y, Mochizuki Y, Nishikido M, Izumo T, Harada T, Funakoshi S, Matsuo T, Tsujino A, Sakai H, Mukae H, Nishino T.

BMC Nephrol. 2019 Jun 7;20(1):210. doi: 10.1186/s12882-019-1400-4.

4.

Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels.

Kitamura M, Mochizuki Y, Kitamura S, Mukae Y, Nakanishi H, Ota Y, Muta K, Yamashita H, Obata Y, Iwata T, Nishikido M, Kawanami S, Takashima M, Sasaki H, Sakai H, Mukae H, Nishino T.

Ann Transplant. 2019 May 10;24:260-267. doi: 10.12659/AOT.914909.

5.

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.

Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Mukae H, Nishino T.

PLoS One. 2019 Feb 20;14(2):e0211812. doi: 10.1371/journal.pone.0211812. eCollection 2019.

6.

Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Clin Immunol. 2018 Dec;197:161-168. doi: 10.1016/j.clim.2018.10.002. Epub 2018 Oct 5.

PMID:
30296591
7.

Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.

Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Umeda M, Fukui S, Sumiyoshi R, Kitamura M, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Intern Med. 2019 Feb 1;58(3):441-445. doi: 10.2169/internalmedicine.1441-18. Epub 2018 Aug 24.

8.

Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation.

Kitamura M, Hisano S, Kurobe Y, Abe S, Ota Y, Sawayama Y, Uramatsu T, Obata Y, Fukuoka J, Miyazaki Y, Mukae H, Nishino T.

Intern Med. 2019 Jan 1;58(1):91-96. doi: 10.2169/internalmedicine.1251-18. Epub 2018 Aug 24.

9.

Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Omori T, Nakanishi K, Fujimura J, Ashida A, Kitamura M, Kawano M, Shimabukuro W, Kitabayashi C, Imafuku A, Tamagaki K, Kamei K, Okamoto K, Fujinaga S, Oka M, Igarashi T, Miyazono A, Sawanobori E, Fujimaru R, Nakanishi K, Shima Y, Matsuo M, Ye MJ, Nozu Y, Morisada N, Kaito H, Iijima K.

J Am Soc Nephrol. 2018 Aug;29(8):2244-2254. doi: 10.1681/ASN.2018030228. Epub 2018 Jun 29.

10.

A case of mild phenotype Alport syndrome caused by COL4A3 mutations.

Kamijo M, Kitamura M, Muta K, Uramatsu T, Obata Y, Nozu K, Kaito H, Iijima K, Mukae H, Nishino T.

CEN Case Rep. 2017 Nov;6(2):189-193. doi: 10.1007/s13730-017-0273-2. Epub 2017 Aug 30.

11.

A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.

Oka S, Obata Y, Torigoe K, Torigoe M, Abe S, Muta K, Ota Y, Kitamura M, Kawasaki S, Hirose M, Uramatsu T, Yamashita H, Arai H, Mukae H, Nishino T.

Drugs R D. 2017 Sep;17(3):389-396. doi: 10.1007/s40268-017-0188-6.

12.

Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.

Oka S, Obata Y, Sato S, Torigoe K, Sawa M, Abe S, Muta K, Ota Y, Kitamura M, Kawasaki S, Hirose M, Uramatsu T, Mukae H, Nishino T.

Med Sci Monit. 2017 Mar 26;23:1464-1470.

13.

Curcumin ameliorates nephrosclerosis via suppression of histone acetylation independent of hypertension.

Muta K, Obata Y, Oka S, Abe S, Minami K, Kitamura M, Endo D, Koji T, Nishino T.

Nephrol Dial Transplant. 2016 Oct;31(10):1615-23. doi: 10.1093/ndt/gfw036. Epub 2016 Mar 24.

PMID:
27190365
14.

Successful Management of Lupus Nephritis with High Titers of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibodies Using Tacrolimus.

Abe Y, Shima T, Izumi Y, Kitamura M, Yamashita H, Tsuji Y, Sasaki O, Maeda C, Kawahara C, Torisu A, Kawaguchi Y, Kurohama H, Ito M, Iwanaga N, Kawakami A, Nakayama T, Taguchi T, Migita K.

Intern Med. 2015;54(22):2929-33. doi: 10.2169/internalmedicine.54.4343. Epub 2015 Nov 15.

15.

The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice.

Kitamura M, Nishino T, Obata Y, Oka S, Abe S, Muta K, Ozono Y, Koji T, Kohno S.

Biol Pharm Bull. 2015;38(2):193-200. doi: 10.1248/bpb.b14-00469.

16.

New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models.

Kitamura M, Nishino T, Obata Y, Ozono Y, Koji T, Kohno S.

Acta Histochem Cytochem. 2014 Aug 29;47(4):133-43. doi: 10.1267/ahc.14025. Epub 2014 Jul 16.

17.

SAHA Suppresses Peritoneal Fibrosis in Mice.

Io K, Nishino T, Obata Y, Kitamura M, Koji T, Kohno S.

Perit Dial Int. 2015 May-Jun;35(3):246-58. doi: 10.3747/pdi.2013.00089. Epub 2014 Mar 1.

18.

A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.

Hirose M, Nishino T, Uramatsu T, Obata Y, Kitamura M, Kawazu T, Miyazaki M, Taguchi T, Kohno S.

Clin Exp Nephrol. 2012 Jun;16(3):473-9. doi: 10.1007/s10157-011-0580-4. Epub 2012 Jan 19.

PMID:
22258558
19.

Epigallocatechin gallate suppresses peritoneal fibrosis in mice.

Kitamura M, Nishino T, Obata Y, Furusu A, Hishikawa Y, Koji T, Kohno S.

Chem Biol Interact. 2012 Jan 5;195(1):95-104. doi: 10.1016/j.cbi.2011.11.002. Epub 2011 Nov 15.

PMID:
22101032
20.

A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis.

Kitamura M, Furusu A, Hirose M, Nishino T, Obata Y, Uramatsu T, Kohno S.

Clin Exp Nephrol. 2010 Dec;14(6):633-6. doi: 10.1007/s10157-010-0335-7. Epub 2010 Nov 12.

PMID:
21072675

Supplemental Content

Loading ...
Support Center